Recently a conjunction between cancer stem cells and epithelial-mesenchymal transition (EMT) has been reported, and it has been shown that morphological and molecular changes occur when epithelial cells lose their characteristics, gain mesenchymal properties, and become motile, playing a critical role in the invasion of cancer cells [ 16, 17].
The precise molecular changes that occur when a neural stem (NS) cell switches from a programme of self-renewal to commit towards a specific lineage are not currently well understood.
Whether expression of these genes is directly affected by the mechanical environment or as a more indirect consequence of altered cell behaviour is not known; a genome-wide, open ended screen is required to know more about the spectrum of molecular changes that occur when mechanical stimuli are altered.
Specifically, we address the question of how the electronic properties of a molecular layer change when it is patterned on a subnanometer scale.
We also describe the role of PD analyses in clinical trials, including for MOA confirmation and dosage regimen optimization during phase 0 trials as well as for correlating molecular changes with clinical efficacy when establishing proof-of-concept in phase I/II trials.
This means that the genes under study can confer a more aggressive phenotype when molecular changes deregulate at least three of them.
A complex disease is often characterized with many coordinated molecular changes, which should be considered when evaluating the reproducibility of discovery lists from different studies.
The absorbance at 1,115, 1,163, and 1,026 cm−1 is more sensitive to the conformational changes produced during degradation processes, indicating a short range order and helicity changes when crystallinity and molecular orientation are lost.
Transcriptome and proteome analysis were applied to characterize the molecular changes occurring between these two lines when fed a low or a high energy diet.
The prevailing hypothesis is that the reproductive pathology in DES-daughters is defined by transient molecular changes during the crucial developmental period when DES is administrated.
